imipramine

1
Reactions 1496, p25 - 12 Apr 2014 S Imipramine Interstitial lung disease in an elderly patient: case report A 75-year-old woman, who had a psychiatric disorder with sleep disturbances, developed interstitial lung disease during treatment with imipramine. The woman, who had a history of a psychiatric disorder with sleep disturbances for the past 25 years, for which she had been receiving imipramine 25 mg/day [route not stated], presented with a 15-day history of cough and dyspnoea [duration of treatment to reaction onset not stated]. Her cough was associated with a moderate quantity of sputum but with no blood or bile staining. She was hospitalised and her vital signs were as follows: HR, 103/min; BP, 130/70 mmHg; and respiratory rate, 34 cycles/min. Physical examination was normal apart from coarse inspiratory crepitations. Laboratory tests revealed the following: leucocytes, 11 200 cells/mm 3 (eosinophils, 2.3%); erythrocyte sedimentation rate, 55 mm/h; and absolute eosinophil count, 300 cells/mm 3 . A chest x-ray showed bilateral lower zone non-homogeneous opacity. Pulmonary function tests revealed a restrictive lung disease and, as per high-resolution CT scan and chest x-ray reports, she was diagnosed as having chronic interstitial lung disease. Imipramine was suspected to be the cause due to the woman’s long-term exposure to the drug and, on hospital day 6, it was discontinued. As the disease was chronic, there were no dramatic changes in her condition following the drug’s withdrawal. She was discharged with oral corticosteroid therapy and received routine treatment for the disease [patient outcome not stated]. Author comment: "The adverse drug reaction (ADR) was assessed by using the Naranjo scale and the Hartwig scale, and the ADR was found to be ’probable’ (Naranjo score 6) and ’moderate’ (level 4 [B], ie, the ADR was the reason for admission), respectively." Deshpande PR, et al. Interstitial lung disease probably caused by imipramine. American Journal of Therapeutics 21: e66-e68, No. 2, 1 Apr 2014 - India 803101824 1 Reactions 12 Apr 2014 No. 1496 0114-9954/14/1496-0001/$14.95 Adis © 2014 Springer International Publishing AG. All rights reserved

Upload: trantruc

Post on 26-Jan-2017

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Imipramine

Reactions 1496, p25 - 12 Apr 2014

SImipramine

Interstitial lung disease in an elderly patient: casereport

A 75-year-old woman, who had a psychiatric disorder withsleep disturbances, developed interstitial lung disease duringtreatment with imipramine.

The woman, who had a history of a psychiatric disorder withsleep disturbances for the past 25 years, for which she hadbeen receiving imipramine 25 mg/day [route not stated],presented with a 15-day history of cough and dyspnoea[duration of treatment to reaction onset not stated]. Her coughwas associated with a moderate quantity of sputum but withno blood or bile staining. She was hospitalised and her vitalsigns were as follows: HR, 103/min; BP, 130/70 mmHg; andrespiratory rate, 34 cycles/min. Physical examination wasnormal apart from coarse inspiratory crepitations. Laboratorytests revealed the following: leucocytes, 11 200 cells/mm3

(eosinophils, 2.3%); erythrocyte sedimentation rate, 55 mm/h;and absolute eosinophil count, 300 cells/mm3. A chest x-rayshowed bilateral lower zone non-homogeneous opacity.Pulmonary function tests revealed a restrictive lung diseaseand, as per high-resolution CT scan and chest x-ray reports,she was diagnosed as having chronic interstitial lung disease.

Imipramine was suspected to be the cause due to thewoman’s long-term exposure to the drug and, on hospitalday 6, it was discontinued. As the disease was chronic, therewere no dramatic changes in her condition following thedrug’s withdrawal. She was discharged with oral corticosteroidtherapy and received routine treatment for the disease [patientoutcome not stated].

Author comment: "The adverse drug reaction (ADR) wasassessed by using the Naranjo scale and the Hartwig scale,and the ADR was found to be ’probable’ (Naranjo score 6)and ’moderate’ (level 4 [B], ie, the ADR was the reason foradmission), respectively."Deshpande PR, et al. Interstitial lung disease probably caused by imipramine.American Journal of Therapeutics 21: e66-e68, No. 2, 1 Apr 2014 -India 803101824

1

Reactions 12 Apr 2014 No. 14960114-9954/14/1496-0001/$14.95 Adis © 2014 Springer International Publishing AG. All rights reserved